@article{10.11648/j.ijn.20230702.16,
  author = {William Bolton and Fozia Saeed and Sandeep Solanki and Gnanamurthy Sivakumar and Robert Corns and John Goodden and Paul Chumas and Simon Thomson},
  title = {The Feasibility and Safety of Day Case Brain Tumour Biopsy: An Eight-Year Experience in the United Kingdom},
  journal = {International Journal of Neurosurgery},
  volume = {7},
  number = {2},
  pages = {46-51},
  doi = {10.11648/j.ijn.20230702.16},
  url = {https://doi.org/10.11648/j.ijn.20230702.16},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijn.20230702.16},
  abstract = {Purpose: Day-case surgery for selected procedures has the potential to reduce healthcare costs and improve patient experience. In neurosurgery, brain biopsies have been performed as day-case procedures for selected patients. The purpose of this study is to demonstrate the safety and feasibility of a clinical pathway that facilitates day-case brain biopsy surgery to improve the generalisability of the evidence and inform wider adoption of this practice. Materials and methods: A single centre, retrospective study of patients aged ≥18 years requiring a brain biopsy for presumed tumour between November 2009 and December 2017 was performed. All patients received pre-admission radiology imaging +/- trajectory planning (as required), an operation on a morning theatre list and post-biopsy CT head 4-6 hours to rule out haemorrhage or other complications. Discharge was aimed at 6 hours post-biopsy if observations and CT were satisfactory. All data was collected via an institution operative database and descriptive statistical analysis was conducted. Results: A total of 447 brain tumour biopsies performed over the eight-year study period of which a total of n=160 (35.8%) were planned day-case. The proportion of biopsies performed as day-case increased over the study period, from four in 2009 to 33 per annum in 2017, an increase from only 10% (n=4) to 66% (n=33) of the total annual biopsies for this centre. Of the 160 planned day-cases, 135 (84.4%) were actual day-cases and successfully discharged on the same day as the operation. The mean patient age was 58 years. Twenty-five cases had at least one overnight unplanned stay, revealing a failure rate of 15.6%. Conclusions: This study demonstrates the safety of our day-case brain tumour biopsy service and is consistent with other centres’ experiences. This represents an opportunity for neurosurgeons to confidently contribute to an increasing provision of day-case surgery across the service.
},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - The Feasibility and Safety of Day Case Brain Tumour Biopsy: An Eight-Year Experience in the United Kingdom
AU  - William Bolton
AU  - Fozia Saeed
AU  - Sandeep Solanki
AU  - Gnanamurthy Sivakumar
AU  - Robert Corns
AU  - John Goodden
AU  - Paul Chumas
AU  - Simon Thomson
Y1  - 2023/10/31
PY  - 2023
N1  - https://doi.org/10.11648/j.ijn.20230702.16
DO  - 10.11648/j.ijn.20230702.16
T2  - International Journal of Neurosurgery
JF  - International Journal of Neurosurgery
JO  - International Journal of Neurosurgery
SP  - 46
EP  - 51
PB  - Science Publishing Group
SN  - 2640-1959
UR  - https://doi.org/10.11648/j.ijn.20230702.16
AB  - Purpose: Day-case surgery for selected procedures has the potential to reduce healthcare costs and improve patient experience. In neurosurgery, brain biopsies have been performed as day-case procedures for selected patients. The purpose of this study is to demonstrate the safety and feasibility of a clinical pathway that facilitates day-case brain biopsy surgery to improve the generalisability of the evidence and inform wider adoption of this practice. Materials and methods: A single centre, retrospective study of patients aged ≥18 years requiring a brain biopsy for presumed tumour between November 2009 and December 2017 was performed. All patients received pre-admission radiology imaging +/- trajectory planning (as required), an operation on a morning theatre list and post-biopsy CT head 4-6 hours to rule out haemorrhage or other complications. Discharge was aimed at 6 hours post-biopsy if observations and CT were satisfactory. All data was collected via an institution operative database and descriptive statistical analysis was conducted. Results: A total of 447 brain tumour biopsies performed over the eight-year study period of which a total of n=160 (35.8%) were planned day-case. The proportion of biopsies performed as day-case increased over the study period, from four in 2009 to 33 per annum in 2017, an increase from only 10% (n=4) to 66% (n=33) of the total annual biopsies for this centre. Of the 160 planned day-cases, 135 (84.4%) were actual day-cases and successfully discharged on the same day as the operation. The mean patient age was 58 years. Twenty-five cases had at least one overnight unplanned stay, revealing a failure rate of 15.6%. Conclusions: This study demonstrates the safety of our day-case brain tumour biopsy service and is consistent with other centres’ experiences. This represents an opportunity for neurosurgeons to confidently contribute to an increasing provision of day-case surgery across the service.

VL  - 7
IS  - 2
ER  - 

Copy | Download